21 – 30 of 624
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Personcentrad digital och interaktiv palliativ vård
(2025) Vitalis: The largest eHealth event in Scandinavia
- Contribution to conference › Abstract
-
Mark
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
- Contribution to journal › Article
-
Mark
High-risk human papillomavirus genotypes in previously unscreened reproductive-age women in Ethiopia : A community-based cohort study
- Contribution to journal › Article
-
Mark
Response-Letter to the Editor : Consensus Statements on End-Of-Life Care in ICU
- Contribution to journal › Article
-
Mark
Validation of a breast cancer assay for radiotherapy omission : an individual participant data meta-analysis
- Contribution to journal › Article
-
Mark
Peripheral T- and natural killer-cell lymphomas : ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
- Contribution to journal › Article
-
Mark
Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies
- Contribution to journal › Article
-
Mark
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH) : a randomised, open-label, phase 2/3 superiority trial
- Contribution to journal › Article
-
Mark
Janus kinase 1 inhibitors for treating immune checkpoint inhibitor-induced enterocolitis - report of two filgotinib-treated cases and literature review
- Contribution to journal › Scientific review
-
Mark
Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies
- Contribution to journal › Letter
